Aamir Mecklai is a Managing Director within the Global Healthcare Group, based in New York. Aamir specializes in the pharmaceutical and biotech sector.

Aamir has been with BofA Securities for 14 years and is a healthcare investment banker covering global pharmaceutical companies and biotech companies (both public and private). His product focus is on strategic advisory (i.e. M&A and strategic partnerships) and capital issuances (i.e. equity, debt, royalty, and convertibles). Aamir previously worked at Pfizer for 10 years in the global manufacturing / operations division responsible for active pharmaceutical ingredient production.

Aamir holds a B.S. in Chemical Engineering from MIT and an MBA from Kellogg School of Management (Northwestern University).